The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 44,458 | 486,250 | SH | SOLE | 486,250 | 0 | 0 | ||
AbbVie Inc. | Common | 00287Y109 | 52,401 | 533,725 | SH | SOLE | 533,725 | 0 | 0 | ||
ABIOMED, Inc. | Common | 003654100 | 3,815 | 15,794 | SH | SOLE | 15,794 | 0 | 0 | ||
AC Immune SA | Shares | H00263105 | 1,156 | 171,813 | SH | SOLE | 171,813 | 0 | 0 | ||
Acadia Healthcare Company, Inc. | Common | 00404A109 | 3,296 | 131,200 | SH | SOLE | 131,200 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 12,154 | 250,743 | SH | SOLE | 250,743 | 0 | 0 | ||
Acceleron Pharma Inc. | Common | 00434H108 | 3,869 | 40,606 | SH | SOLE | 40,606 | 0 | 0 | ||
Addus HomeCare Corp. | Common | 006739106 | 1,478 | 15,969 | SH | SOLE | 15,969 | 0 | 0 | ||
Aerie Pharmaceuticals, Inc. | Common | 00771V108 | 984 | 66,688 | SH | SOLE | 66,688 | 0 | 0 | ||
Aerpio Pharmaceuticals, Inc. | Common | 00810B105 | 322 | 257,554 | SH | SOLE | 257,554 | 0 | 0 | ||
Agilent Technologies, Inc. | Common | 00846U101 | 4,642 | 52,525 | SH | SOLE | 52,525 | 0 | 0 | ||
Agios Pharmaceuticals, Inc. | Common | 00847X104 | 9,999 | 186,964 | SH | SOLE | 186,964 | 0 | 0 | ||
Alcon Inc. | Ordinary Shares | H01301128 | 2,103 | 36,686 | SH | SOLE | 36,686 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 43,180 | 384,709 | SH | SOLE | 384,709 | 0 | 0 | ||
Align Technology, Inc. | Common | 016255101 | 2,756 | 10,041 | SH | SOLE | 10,041 | 0 | 0 | ||
Alkermes plc | Shares | G01767105 | 3,297 | 169,930 | SH | SOLE | 169,930 | 0 | 0 | ||
Allakos Inc. | Common | 01671P100 | 4,628 | 64,397 | SH | SOLE | 64,397 | 0 | 0 | ||
Allogene Therapeutics, Inc. | Common | 019770106 | 9,252 | 216,069 | SH | SOLE | 216,069 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 18,642 | 125,867 | SH | SOLE | 125,867 | 0 | 0 | ||
Amarin Corporation plc | Sponsored ADR | 023111206 | 5,879 | 849,588 | SH | SOLE | 849,588 | 0 | 0 | ||
Amedisys, Inc. | Common | 023436108 | 3,851 | 19,395 | SH | SOLE | 19,395 | 0 | 0 | ||
AmerisourceBergen Corp. | Common | 03073E105 | 8,127 | 80,645 | SH | SOLE | 80,645 | 0 | 0 | ||
Amgen Inc. | Common | 031162100 | 144,337 | 611,962 | SH | SOLE | 611,962 | 0 | 0 | ||
Amicus Therapeutics, Inc. | Common | 03152W109 | 5,082 | 336,984 | SH | SOLE | 336,984 | 0 | 0 | ||
AnaptysBio, Inc. | Common | 032724106 | 2,642 | 118,261 | SH | SOLE | 118,261 | 0 | 0 | ||
Anthem, Inc. | Common | 036752103 | 10,583 | 40,242 | SH | SOLE | 40,242 | 0 | 0 | ||
Apellis Pharmaceuticals, Inc. | Common | 03753U106 | 5,666 | 173,494 | SH | SOLE | 173,494 | 0 | 0 | ||
ARCA biopharma, Inc. | Common | 00211Y506 | 215 | 32,461 | SH | SOLE | 32,461 | 0 | 0 | ||
Ardelyx, Inc. | Common | 039697107 | 4,205 | 607,698 | SH | SOLE | 607,698 | 0 | 0 | ||
Arena Pharmaceuticals, Inc. | Common | 040047607 | 5,540 | 88,002 | SH | SOLE | 88,002 | 0 | 0 | ||
argenx SE | Sponsored ADR | 04016X101 | 10,130 | 44,977 | SH | SOLE | 44,977 | 0 | 0 | ||
Arrowhead Pharmaceuticals, Inc. | Common | 04280A100 | 3,204 | 74,186 | SH | SOLE | 74,186 | 0 | 0 | ||
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 8,502 | 57,482 | SH | SOLE | 57,482 | 0 | 0 | ||
Assertio Holdings, Inc. | Common | 04546C106 | 1,407 | 1,642,302 | SH | SOLE | 1,642,302 | 0 | 0 | ||
AstraZeneca PLC | Sponsored ADR | 046353108 | 12,418 | 234,798 | SH | SOLE | 234,798 | 0 | 0 | ||
Atreca, Inc. | Class A Common | 04965G109 | 7,500 | 352,424 | SH | SOLE | 352,424 | 0 | 0 | ||
Aurinia Pharmaceuticals Inc. | Common | 05156V102 | 1,475 | 90,788 | SH | SOLE | 90,788 | 0 | 0 | ||
Avadel Pharmaceuticals plc | Sponsored ADR | 05337M104 | 1,888 | 233,612 | SH | SOLE | 233,612 | 0 | 0 | ||
AVROBIO, Inc. | Common | 05455M100 | 2,453 | 140,581 | SH | SOLE | 140,581 | 0 | 0 | ||
Axonics Modulation Technologies, Inc. | Common | 05465P101 | 987 | 28,100 | SH | SOLE | 28,100 | 0 | 0 | ||
Axsome Therapeutics, Inc. | Common | 05464T104 | 2,599 | 31,591 | SH | SOLE | 31,591 | 0 | 0 | ||
Bausch Health Companies Inc. | Common | 071734107 | 2,166 | 118,412 | SH | SOLE | 118,412 | 0 | 0 | ||
Baxter International Inc. | Common | 071813109 | 10,506 | 122,023 | SH | SOLE | 122,023 | 0 | 0 | ||
Becton, Dickinson and Co. | Common | 075887109 | 18,604 | 77,754 | SH | SOLE | 77,754 | 0 | 0 | ||
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 14,127 | 74,984 | SH | SOLE | 74,984 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | Common | 079481404 | 45 | 6,000 | SH | SOLE | 6,000 | 0 | 0 | ||
Bio-Techne Corp. | Common | 09073M104 | 13,655 | 51,710 | SH | SOLE | 51,710 | 0 | 0 | ||
Biogen Inc. | Common | 09062X103 | 62,499 | 233,599 | SH | SOLE | 233,599 | 0 | 0 | ||
Biohaven Pharmaceutical Holding Company Ltd. | Common | G11196105 | 2,506 | 34,277 | SH | SOLE | 34,277 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 30,263 | 245,362 | SH | SOLE | 245,362 | 0 | 0 | ||
bluebird bio, Inc. | Common | 09609G100 | 5,139 | 84,194 | SH | SOLE | 84,194 | 0 | 0 | ||
Blueprint Medicines Corp. | Common | 09627Y109 | 9,224 | 118,256 | SH | SOLE | 118,256 | 0 | 0 | ||
Boston Scientific Corp. | Common | 101137107 | 22,644 | 644,935 | SH | SOLE | 644,935 | 0 | 0 | ||
BridgeBio Pharma, Inc. | Common | 10806X102 | 1,279 | 39,228 | SH | SOLE | 39,228 | 0 | 0 | ||
Bristol-Myers Squibb Co. | Common | 110122108 | 57,477 | 977,505 | SH | SOLE | 977,505 | 0 | 0 | ||
Bristol-Myers Squibb Co. | Right | 110122157 | 5,276 | 1,473,710 | SH | SOLE | 1,473,710 | 0 | 0 | ||
Celldex Therapeutics, Inc. | Common | 15117B202 | 92 | 7,053 | SH | SOLE | 7,053 | 0 | 0 | ||
Cellectis | Sponsored ADR | 15117K103 | 1,961 | 110,147 | SH | SOLE | 110,147 | 0 | 0 | ||
Centene Corp. | Common | 15135B101 | 18,315 | 288,194 | SH | SOLE | 288,194 | 0 | 0 | ||
Cerner Corp. | Common | 156782104 | 5,587 | 81,500 | SH | SOLE | 81,500 | 0 | 0 | ||
Charles River Laboratories International, Inc. | Common | 159864107 | 3,220 | 18,467 | SH | SOLE | 18,467 | 0 | 0 | ||
Cidara Therapeutics, Inc. | Common | 171757107 | 720 | 195,256 | SH | SOLE | 195,256 | 0 | 0 | ||
Cigna Corp. | Common | 125523100 | 15,010 | 79,988 | SH | SOLE | 79,988 | 0 | 0 | ||
Clearside Biomedical, Inc. | Common | 185063104 | 311 | 165,330 | SH | SOLE | 165,330 | 0 | 0 | ||
Coherus Biosciences, Inc. | Common | 19249H103 | 3,627 | 203,103 | SH | SOLE | 203,103 | 0 | 0 | ||
Community Health Systems, Inc. | Common | 203668108 | 354 | 117,735 | SH | SOLE | 117,735 | 0 | 0 | ||
Community Healthcare Trust Inc. | Common | 20369C106 | 609 | 14,900 | SH | SOLE | 14,900 | 0 | 0 | ||
Corbus Pharmaceuticals Holdings, Inc. | Common | 21833P103 | 3,177 | 378,706 | SH | SOLE | 378,706 | 0 | 0 | ||
CRISPR Therapeutics AG | Namen AKT | H17182108 | 5,602 | 76,222 | SH | SOLE | 76,222 | 0 | 0 | ||
CVS Health Corp. | Common | 126650100 | 46,754 | 719,620 | SH | SOLE | 719,620 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | Common | 23257D103 | 307 | 88,102 | SH | SOLE | 88,102 | 0 | 0 | ||
Danaher Corp. | Common | 235851102 | 28,178 | 159,352 | SH | SOLE | 159,352 | 0 | 0 | ||
Deciphera Pharmaceuticals, Inc. | Common | 24344T101 | 3,665 | 61,370 | SH | SOLE | 61,370 | 0 | 0 | ||
DENTSPLY SIRONA Inc. | Common | 24906P109 | 7,106 | 161,287 | SH | SOLE | 161,287 | 0 | 0 | ||
DexCom, Inc. | Common | 252131107 | 2,940 | 7,251 | SH | SOLE | 7,251 | 0 | 0 | ||
Diversified Healthcare Trust | Common | 25525P107 | 1,583 | 357,720 | SH | SOLE | 357,720 | 0 | 0 | ||
Editas Medicine, Inc. | Common | 28106W103 | 3,851 | 130,201 | SH | SOLE | 130,201 | 0 | 0 | ||
Edwards Lifesciences Corp. | Common | 28176E108 | 13,970 | 202,146 | SH | SOLE | 202,146 | 0 | 0 | ||
Eidos Therapeutics, Inc. | Common | 28249H104 | 953 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Eli Lilly and Co. | Common | 532457108 | 33,958 | 206,837 | SH | SOLE | 206,837 | 0 | 0 | ||
Endo International plc | Shares | G30401106 | 1,823 | 531,570 | SH | SOLE | 531,570 | 0 | 0 | ||
Epizyme, Inc. | Common | 29428V104 | 3,336 | 207,752 | SH | SOLE | 207,752 | 0 | 0 | ||
Esperion Therapeutics, Inc. | Common | 29664W105 | 2,133 | 41,577 | SH | SOLE | 41,577 | 0 | 0 | ||
Evolent Health, Inc. | Common | 30050B101 | 1,645 | 231,027 | SH | SOLE | 231,027 | 0 | 0 | ||
Exact Sciences Corp. | Common | 30063P105 | 3,827 | 44,015 | SH | SOLE | 44,015 | 0 | 0 | ||
Exelixis, Inc. | Common | 30161Q104 | 22,172 | 933,949 | SH | SOLE | 933,949 | 0 | 0 | ||
Fate Therapeutics, Inc. | Common | 31189P102 | 6,370 | 185,672 | SH | SOLE | 185,672 | 0 | 0 | ||
FibroGen, Inc. | Common | 31572Q808 | 7,874 | 194,270 | SH | SOLE | 194,270 | 0 | 0 | ||
Five Star Senior Living Inc. | Common | 33832D205 | 95 | 24,237 | SH | SOLE | 24,237 | 0 | 0 | ||
Galapagos NV | Sponsored ADR | 36315X101 | 1,291 | 6,543 | SH | SOLE | 6,543 | 0 | 0 | ||
Galera Therapeutics, Inc. | Common | 36338D108 | 7,439 | 1,041,845 | SH | SOLE | 1,041,845 | 0 | 0 | ||
Genmab A/S | Sponsored ADS | 372303206 | 560 | 16,520 | SH | SOLE | 16,520 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 121,644 | 1,581,026 | SH | SOLE | 1,581,026 | 0 | 0 | ||
GlaxoSmithKline PLC | Shares | 37733W105 | 8,985 | 220,263 | SH | SOLE | 220,263 | 0 | 0 | ||
Global Blood Therapeutics, Inc. | Common | 37890U108 | 4,530 | 71,759 | SH | SOLE | 71,759 | 0 | 0 | ||
Global Medical REIT Inc. | Common | 37954A204 | 1,982 | 174,897 | SH | SOLE | 174,897 | 0 | 0 | ||
Grifols, S.A. | Sponsored ADR | 398438408 | 864 | 47,373 | SH | SOLE | 47,373 | 0 | 0 | ||
Guardant Health, Inc. | Common | 40131M109 | 6,606 | 81,422 | SH | SOLE | 81,422 | 0 | 0 | ||
GW Pharmaceuticals plc | ADS | 36197T103 | 3,074 | 25,051 | SH | SOLE | 25,051 | 0 | 0 | ||
Halozyme Therapeutics, Inc. | Common | 40637H109 | 1,874 | 69,917 | SH | SOLE | 69,917 | 0 | 0 | ||
HCA Healthcare, Inc. | Common | 40412C101 | 8,137 | 83,833 | SH | SOLE | 83,833 | 0 | 0 | ||
Health Care Select Sector SPDR Fund | SBI Healthcare | 81369Y209 | 1,006 | 10,055 | SH | SOLE | 10,055 | 0 | 0 | ||
Healthcare Realty Trust Inc. | Common | 421946104 | 3,047 | 104,024 | SH | SOLE | 104,024 | 0 | 0 | ||
Healthcare Trust of America, Inc. | Common | 42225P501 | 1,874 | 70,662 | SH | SOLE | 70,662 | 0 | 0 | ||
Healthpeak Properties, Inc. | Common | 42250P103 | 4,145 | 150,392 | SH | SOLE | 150,392 | 0 | 0 | ||
Heron Therapeutics, Inc. | Common | 427746102 | 1,930 | 131,183 | SH | SOLE | 131,183 | 0 | 0 | ||
Hologic, Inc. | Common | 436440101 | 1,856 | 32,564 | SH | SOLE | 32,564 | 0 | 0 | ||
Horizon Therapeutics plc | Shares | G46188101 | 22,796 | 410,153 | SH | SOLE | 410,153 | 0 | 0 | ||
Humana Inc. | Common | 444859102 | 18,808 | 48,506 | SH | SOLE | 48,506 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 12,221 | 37,014 | SH | SOLE | 37,014 | 0 | 0 | ||
Illumina, Inc. | Common | 452327109 | 79,496 | 214,651 | SH | SOLE | 214,651 | 0 | 0 | ||
ImmunoGen, Inc. | Common | 45253H101 | 774 | 168,190 | SH | SOLE | 168,190 | 0 | 0 | ||
Immunomedics, Inc. | Common | 452907108 | 17,617 | 497,103 | SH | SOLE | 497,103 | 0 | 0 | ||
Incyte Corp. | Common | 45337C102 | 33,796 | 325,053 | SH | SOLE | 325,053 | 0 | 0 | ||
Innate Pharma SA | Sponsored ADS | B1G5FB909 | 858 | 137,734 | SH | SOLE | 137,734 | 0 | 0 | ||
Inogen, Inc. | Common | 45780L104 | 1,826 | 51,406 | SH | SOLE | 51,406 | 0 | 0 | ||
Inovio Pharmaceuticals, Inc. | Common | 45773H201 | 5,445 | 202,038 | SH | SOLE | 202,038 | 0 | 0 | ||
Insmed Inc. | Common | 457669307 | 2,710 | 98,387 | SH | SOLE | 98,387 | 0 | 0 | ||
Intellia Therapeutics, Inc. | Common | 45826J105 | 1,157 | 55,050 | SH | SOLE | 55,050 | 0 | 0 | ||
Intercept Pharmaceuticals, Inc. | Common | 45845P108 | 3,692 | 77,067 | SH | SOLE | 77,067 | 0 | 0 | ||
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 2,419 | 94,238 | SH | SOLE | 94,238 | 0 | 0 | ||
Intuitive Surgical, Inc. | Common | 46120E602 | 18,998 | 33,339 | SH | SOLE | 33,339 | 0 | 0 | ||
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 11,391 | 193,201 | SH | SOLE | 193,201 | 0 | 0 | ||
Iovance Biotherapeutics, Inc. | Common | 462260100 | 7,441 | 271,073 | SH | SOLE | 271,073 | 0 | 0 | ||
IQVIA Holdings Inc. | Common | 46266C105 | 11,672 | 82,266 | SH | SOLE | 82,266 | 0 | 0 | ||
Jazz Pharmaceuticals plc | Shares | G50871105 | 7,443 | 67,456 | SH | SOLE | 67,456 | 0 | 0 | ||
Johnson & Johnson | Common | 478160104 | 116,727 | 830,031 | SH | SOLE | 830,031 | 0 | 0 | ||
Karuna Therapeutics, Inc. | Common | 48576A100 | 3,330 | 29,873 | SH | SOLE | 29,873 | 0 | 0 | ||
Kodiak Sciences Inc. | Common | 50015M109 | 1,253 | 23,153 | SH | SOLE | 23,153 | 0 | 0 | ||
Koninklijke Philips N.V. | NY Reg Sh | 500472303 | 2,613 | 55,796 | SH | SOLE | 55,796 | 0 | 0 | ||
Laboratory Corporation of America Holdings | Sponsored ADR | 50540R409 | 7,849 | 47,251 | SH | SOLE | 47,251 | 0 | 0 | ||
Ligand Pharmaceuticals Inc. | Common | 53220K504 | 3,421 | 30,590 | SH | SOLE | 30,590 | 0 | 0 | ||
LTC Properties, Inc. | Common | 502175102 | 6,867 | 182,293 | SH | SOLE | 182,293 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | Common | 558868105 | 1,511 | 13,340 | SH | SOLE | 13,340 | 0 | 0 | ||
Magenta Therapeutics, Inc. | Common | 55910K108 | 1,445 | 192,431 | SH | SOLE | 192,431 | 0 | 0 | ||
Mallinckrodt plc | Sponsored ADR | G5785G107 | 88 | 32,980 | SH | SOLE | 32,980 | 0 | 0 | ||
McKesson Corp. | Common | 58155Q103 | 16,498 | 107,537 | SH | SOLE | 107,537 | 0 | 0 | ||
Medical Properties Trust, Inc. | Common | 58463J304 | 7,741 | 411,743 | SH | SOLE | 411,743 | 0 | 0 | ||
Medpace Holdings, Inc. | Common | 58506Q109 | 1,755 | 18,871 | SH | SOLE | 18,871 | 0 | 0 | ||
Medtronic plc | Shares | G5960L103 | 43,602 | 475,489 | SH | SOLE | 475,489 | 0 | 0 | ||
Menlo Therapeutics Inc. | Common | 586858102 | 937 | 541,584 | SH | SOLE | 541,584 | 0 | 0 | ||
Merck & Co., Inc. | Common | 58933Y105 | 75,126 | 971,496 | SH | SOLE | 971,496 | 0 | 0 | ||
Mettler-Toledo International Inc. | Common | 592688105 | 4,932 | 6,123 | SH | SOLE | 6,123 | 0 | 0 | ||
Milestone Pharmaceuticals Inc. | Common | 59935V107 | 806 | 213,310 | SH | SOLE | 213,310 | 0 | 0 | ||
Mirati Therapeutics, Inc. | Common | 60468T105 | 8,995 | 78,784 | SH | SOLE | 78,784 | 0 | 0 | ||
Moderna, Inc. | Common | 60770K107 | 31,624 | 492,506 | SH | SOLE | 492,506 | 0 | 0 | ||
Molecular Templates, Inc. | Common | 608550109 | 583 | 42,313 | SH | SOLE | 42,313 | 0 | 0 | ||
Molina Healthcare, Inc. | Common | 60855R100 | 4,901 | 27,536 | SH | SOLE | 27,536 | 0 | 0 | ||
Momenta Pharmaceuticals, Inc. | Common | 60877T100 | 3,719 | 111,768 | SH | SOLE | 111,768 | 0 | 0 | ||
MorphoSys AG | Sponsored ADS | 617760202 | 614 | 19,390 | SH | SOLE | 19,390 | 0 | 0 | ||
Mylan N.V. | Shares | N59465109 | 16,253 | 1,010,754 | SH | SOLE | 1,010,754 | 0 | 0 | ||
MyoKardia, Inc. | Common | 62857M105 | 1,865 | 19,300 | SH | SOLE | 19,300 | 0 | 0 | ||
National Health Investors, Inc. | Common | 63633D104 | 610 | 10,038 | SH | SOLE | 10,038 | 0 | 0 | ||
Nektar Therapeutics | Common | 640268108 | 6,093 | 263,079 | SH | SOLE | 263,079 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 25,150 | 206,150 | SH | SOLE | 206,150 | 0 | 0 | ||
New Senior Investment Group Inc. | Common | 648691103 | 928 | 256,398 | SH | SOLE | 256,398 | 0 | 0 | ||
Novartis AG | Sponsored ADR | 66987V109 | 14,936 | 171,008 | SH | SOLE | 171,008 | 0 | 0 | ||
Novavax, Inc. | Common | 670002401 | 2,380 | 28,550 | SH | SOLE | 28,550 | 0 | 0 | ||
Novo Nordisk A/S | Sponsored ADR | 670100205 | 8,775 | 134,005 | SH | SOLE | 134,005 | 0 | 0 | ||
NovoCure Ltd. | Ordinary Shares | G6674U108 | 7,806 | 131,637 | SH | SOLE | 131,637 | 0 | 0 | ||
Omega Healthcare Investors, Inc. | Common | 681936100 | 9,110 | 306,433 | SH | SOLE | 306,433 | 0 | 0 | ||
Ovid Therapeutics Inc. | Sponsored ADR | 690469101 | 2,747 | 372,733 | SH | SOLE | 372,733 | 0 | 0 | ||
Pacific Biosciences of California, Inc. | Common | 69404D108 | 1,709 | 495,495 | SH | SOLE | 495,495 | 0 | 0 | ||
PerkinElmer, Inc. | Common | 714046109 | 3,776 | 38,494 | SH | SOLE | 38,494 | 0 | 0 | ||
Perrigo Company plc | Shares | G97822103 | 2,831 | 51,224 | SH | SOLE | 51,224 | 0 | 0 | ||
Pfizer Inc. | Common | 717081103 | 54,169 | 1,656,548 | SH | SOLE | 1,656,548 | 0 | 0 | ||
Physicians Realty Trust | Common | 71943U104 | 8,685 | 495,733 | SH | SOLE | 495,733 | 0 | 0 | ||
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 4,493 | 1,449,269 | SH | SOLE | 1,449,269 | 0 | 0 | ||
Portola Pharmaceuticals, Inc. | Sponsored ADR | 737010108 | 1,965 | 109,246 | SH | SOLE | 109,246 | 0 | 0 | ||
PRA Health Sciences, Inc. | Common | 69354M108 | 13,962 | 143,508 | SH | SOLE | 143,508 | 0 | 0 | ||
Principia Biopharma Inc. | Common | 74257L108 | 3,611 | 60,390 | SH | SOLE | 60,390 | 0 | 0 | ||
PTC Therapeutics, Inc. | Common | 69366J200 | 6,131 | 120,827 | SH | SOLE | 120,827 | 0 | 0 | ||
Puma Biotechnology, Inc. | Common | 74587V107 | 744 | 71,340 | SH | SOLE | 71,340 | 0 | 0 | ||
Quest Diagnostics Inc. | Common | 74834L100 | 2,396 | 21,025 | SH | SOLE | 21,025 | 0 | 0 | ||
Quotient Ltd. | Common | G73268107 | 3,048 | 411,937 | SH | SOLE | 411,937 | 0 | 0 | ||
Reata Pharmaceuticals, Inc. | Class A | 75615P103 | 7,943 | 50,907 | SH | SOLE | 50,907 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 117,206 | 187,935 | SH | SOLE | 187,935 | 0 | 0 | ||
REGENXBIO Inc. | Common | 75901B107 | 799 | 21,700 | SH | SOLE | 21,700 | 0 | 0 | ||
ResMed Inc. | Common | 761152107 | 3,424 | 17,831 | SH | SOLE | 17,831 | 0 | 0 | ||
Revance Therapeutics, Inc. | Common | 761330109 | 2,096 | 85,840 | SH | SOLE | 85,840 | 0 | 0 | ||
Rocket Pharmaceuticals, Inc. | Common | 77313F106 | 6,049 | 289,029 | SH | SOLE | 289,029 | 0 | 0 | ||
Rubius Therapeutics, Inc. | Common | 78116T103 | 933 | 155,982 | SH | SOLE | 155,982 | 0 | 0 | ||
Sabra Health Care REIT, Inc. | Common | 78573L106 | 7,369 | 510,660 | SH | SOLE | 510,660 | 0 | 0 | ||
Sage Therapeutics Inc | Common | 78667J108 | 4,000 | 96,211 | SH | SOLE | 96,211 | 0 | 0 | ||
Sangamo Therapeutics, Inc. | Common | 800677106 | 1,343 | 149,835 | SH | SOLE | 149,835 | 0 | 0 | ||
Sanofi | Sponsored ADR | 80105N105 | 16,712 | 327,367 | SH | SOLE | 327,367 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | Common | 803607100 | 22,468 | 140,129 | SH | SOLE | 140,129 | 0 | 0 | ||
Seattle Genetics, Inc. | Common | 812578102 | 40,876 | 240,559 | SH | SOLE | 240,559 | 0 | 0 | ||
Smith & Nephew plc | Shares | 83175M205 | 3,795 | 99,560 | SH | SOLE | 99,560 | 0 | 0 | ||
Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | 388 | 114,670 | SH | SOLE | 114,670 | 0 | 0 | ||
STERIS plc | Shares | G8473T100 | 1,721 | 11,218 | SH | SOLE | 11,218 | 0 | 0 | ||
Stryker Corp. | Common | 863667101 | 29,593 | 164,230 | SH | SOLE | 164,230 | 0 | 0 | ||
Sutro Biopharma, Inc. | Common | 869367102 | 4,976 | 641,268 | SH | SOLE | 641,268 | 0 | 0 | ||
Syneos Health, Inc. | Class A | 87166B102 | 6,291 | 108,001 | SH | SOLE | 108,001 | 0 | 0 | ||
Takeda Pharmaceutical Company Ltd. | Sponsored ADS | 874060205 | 3,768 | 210,146 | SH | SOLE | 210,146 | 0 | 0 | ||
Teleflex Inc. | Common | 879369106 | 6,279 | 17,252 | SH | SOLE | 17,252 | 0 | 0 | ||
Tenet Healthcare Corp. | Common | 88033G407 | 1,752 | 96,736 | SH | SOLE | 96,736 | 0 | 0 | ||
Tetraphase Pharmaceuticals, Inc. | Common | 88165N204 | 108 | 42,965 | SH | SOLE | 42,965 | 0 | 0 | ||
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 9,690 | 785,851 | SH | SOLE | 785,851 | 0 | 0 | ||
Theravance Biopharma, Inc. | Common | G8807B106 | 4,803 | 228,836 | SH | SOLE | 228,836 | 0 | 0 | ||
Thermo Fisher Scientific Inc. | Common | 883556102 | 38,417 | 106,025 | SH | SOLE | 106,025 | 0 | 0 | ||
Tricida, Inc. | Common | 89610F101 | 1,384 | 50,370 | SH | SOLE | 50,370 | 0 | 0 | ||
Trillium Therapeutics Inc. | Common | 89620X506 | 3,625 | 448,049 | SH | SOLE | 448,049 | 0 | 0 | ||
Turning Point Therapeutics, Inc. | Common | 90041T108 | 367 | 5,677 | SH | SOLE | 5,677 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 7,625 | 97,480 | SH | SOLE | 97,480 | 0 | 0 | ||
uniQure N.V. | Shares | N90064101 | 2,841 | 63,039 | SH | SOLE | 63,039 | 0 | 0 | ||
United Therapeutics Corp. | Class B | 91307C102 | 7,685 | 63,513 | SH | SOLE | 63,513 | 0 | 0 | ||
Unitedhealth Group Inc. | Common | 91324P102 | 82,631 | 280,151 | SH | SOLE | 280,151 | 0 | 0 | ||
Universal Health Realty Income Trust | Shares | 91359E105 | 895 | 11,258 | SH | SOLE | 11,258 | 0 | 0 | ||
Ventas, Inc. | Common | 92276F100 | 7,621 | 208,108 | SH | SOLE | 208,108 | 0 | 0 | ||
Verona Pharma plc | Sponsored ADR | 925050106 | 1,182 | 253,179 | SH | SOLE | 253,179 | 0 | 0 | ||
Vertex Pharmaceuticals Inc. | Common | 92532F100 | 138,574 | 477,330 | SH | SOLE | 477,330 | 0 | 0 | ||
Waters Corporation | Common | 941848103 | 6,708 | 37,184 | SH | SOLE | 37,184 | 0 | 0 | ||
WaVe Life Sciences Ltd. | Shares | Y95308105 | 1,334 | 128,146 | SH | SOLE | 128,146 | 0 | 0 | ||
Welltower Inc. | Common | 95040Q104 | 10,510 | 203,083 | SH | SOLE | 203,083 | 0 | 0 | ||
Xencor, Inc. | Common | 98401F105 | 4,801 | 148,231 | SH | SOLE | 148,231 | 0 | 0 | ||
Y-mAbs Therapeutics, Inc. | Common | 984241109 | 3,307 | 76,548 | SH | SOLE | 76,548 | 0 | 0 | ||
Zai Lab Ltd. | ADR | 98887Q104 | 3,082 | 37,523 | SH | SOLE | 37,523 | 0 | 0 | ||
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 11,298 | 94,653 | SH | SOLE | 94,653 | 0 | 0 | ||
Zoetis Inc. | Class A | 98978V103 | 11,117 | 81,121 | SH | SOLE | 81,121 | 0 | 0 | ||
Zogenix, Inc. | Common | 98978L204 | 5,818 | 215,406 | SH | SOLE | 215,406 | 0 | 0 | ||
Zymeworks Inc. | Common | 98985W102 | 2,018 | 55,938 | SH | SOLE | 55,938 | 0 | 0 |